Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma.
Saved in:
| Title: | Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma. |
|---|---|
| Authors: | Mateos MV; Hospital Universitario de Salamanca, Salamanca, Spain. mvmateos@usal.es., Gavriatopoulou M; Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Facon T; CHU Lille Service Des Maladies du Sang, 59000, Lille, France., Auner HW; Imperial College London, London, UK., Leleu X; Department of Hematology, CHU La Miletrie and Inserm CIC 1402, Poitiers, France., Hájek R; Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic., Dimopoulos MA; National and Kapodistrian University of Athens, Athens, Greece., Delimpasi S; General Hospital Evangelismos, Athens, Greece., Simonova M; Institute of Blood Pathology and Transfusion Medicine of NAMS of Ukraine, Lviv, Ukraine., Špička I; Charles University and General Hospital, Prague, Czech Republic., Pour L; University Hospital Brno, Brno, Czech Republic., Kriachok I; National Cancer Institute, Kiev, Ukraine., Pylypenko H; Cherkassy Regional Oncological Center, Cherkassy, Ukraine., Doronin V; City Clinical Hospital #40, Moscow, Russian Federation., Usenko G; City Clinical Hospital No. 4 of Dnipro City Council, Dnipro, Ukraine., Benjamin R; Kings College Hospital NHS Foundation Trust, London, UK., Dolai TK; Nil Ratan Sircar Medical College and Hospital, Kolkata, India., Sinha DK; State Cancer Institute, Indira Gandhi Institute of Medical Sciences, Patna, India., Venner CP; Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada., Garg M; University Hospitals of Leicester NHS Trust, Leicester, UK., Stevens DA; Norton Cancer Institute, St. Matthews Campus, Louisville, KY, USA., Quach H; St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia., Jagannath S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Moreau P; Hotel-Dieu, University Hospital, Nantes, France., Levy M; Baylor University Medical Center, Dallas, TX, USA., Badros AZ; Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, USA., Anderson LD Jr; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA., Bahlis NJ; Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, USA., Cavo M; Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy., Chai Y; Karyopharm Therapeutics Inc, Newton, MA, USA., Jeha J; Karyopharm Therapeutics Inc, Newton, MA, USA., Arazy M; Karyopharm Therapeutics Inc, Newton, MA, USA., Shah J; Karyopharm Therapeutics Inc, Newton, MA, USA., Shacham S; Karyopharm Therapeutics Inc, Newton, MA, USA., Kauffman MG; Karyopharm Therapeutics Inc, Newton, MA, USA., Richardson PG; Dana Farber Cancer Institute, Boston, MA, USA., Grosicki S; Medical University of Silesia, Katowice, Poland. |
| Source: | Journal of hematology & oncology [J Hematol Oncol] 2021 Apr 13; Vol. 14 (1), pp. 59. Date of Electronic Publication: 2021 Apr 13. |
| Publication Type: | Letter; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33849608 AccessLevel: 2 PubType: Report PubTypeId: report PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mateos+MV%22">Mateos MV</searchLink>; Hospital Universitario de Salamanca, Salamanca, Spain. mvmateos@usal.es.<br /><searchLink fieldCode="AU" term="%22Gavriatopoulou+M%22">Gavriatopoulou M</searchLink>; Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Facon+T%22">Facon T</searchLink>; CHU Lille Service Des Maladies du Sang, 59000, Lille, France.<br /><searchLink fieldCode="AU" term="%22Auner+HW%22">Auner HW</searchLink>; Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Leleu+X%22">Leleu X</searchLink>; Department of Hematology, CHU La Miletrie and Inserm CIC 1402, Poitiers, France.<br /><searchLink fieldCode="AU" term="%22Hájek+R%22">Hájek R</searchLink>; Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Dimopoulos+MA%22">Dimopoulos MA</searchLink>; National and Kapodistrian University of Athens, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Delimpasi+S%22">Delimpasi S</searchLink>; General Hospital Evangelismos, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Simonova+M%22">Simonova M</searchLink>; Institute of Blood Pathology and Transfusion Medicine of NAMS of Ukraine, Lviv, Ukraine.<br /><searchLink fieldCode="AU" term="%22Špička+I%22">Špička I</searchLink>; Charles University and General Hospital, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Pour+L%22">Pour L</searchLink>; University Hospital Brno, Brno, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Kriachok+I%22">Kriachok I</searchLink>; National Cancer Institute, Kiev, Ukraine.<br /><searchLink fieldCode="AU" term="%22Pylypenko+H%22">Pylypenko H</searchLink>; Cherkassy Regional Oncological Center, Cherkassy, Ukraine.<br /><searchLink fieldCode="AU" term="%22Doronin+V%22">Doronin V</searchLink>; City Clinical Hospital #40, Moscow, Russian Federation.<br /><searchLink fieldCode="AU" term="%22Usenko+G%22">Usenko G</searchLink>; City Clinical Hospital No. 4 of Dnipro City Council, Dnipro, Ukraine.<br /><searchLink fieldCode="AU" term="%22Benjamin+R%22">Benjamin R</searchLink>; Kings College Hospital NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Dolai+TK%22">Dolai TK</searchLink>; Nil Ratan Sircar Medical College and Hospital, Kolkata, India.<br /><searchLink fieldCode="AU" term="%22Sinha+DK%22">Sinha DK</searchLink>; State Cancer Institute, Indira Gandhi Institute of Medical Sciences, Patna, India.<br /><searchLink fieldCode="AU" term="%22Venner+CP%22">Venner CP</searchLink>; Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Garg+M%22">Garg M</searchLink>; University Hospitals of Leicester NHS Trust, Leicester, UK.<br /><searchLink fieldCode="AU" term="%22Stevens+DA%22">Stevens DA</searchLink>; Norton Cancer Institute, St. Matthews Campus, Louisville, KY, USA.<br /><searchLink fieldCode="AU" term="%22Quach+H%22">Quach H</searchLink>; St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Jagannath+S%22">Jagannath S</searchLink>; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Moreau+P%22">Moreau P</searchLink>; Hotel-Dieu, University Hospital, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Levy+M%22">Levy M</searchLink>; Baylor University Medical Center, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22Badros+AZ%22">Badros AZ</searchLink>; Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Anderson+LD+Jr%22">Anderson LD Jr</searchLink>; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22Bahlis+NJ%22">Bahlis NJ</searchLink>; Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, USA.<br /><searchLink fieldCode="AU" term="%22Cavo+M%22">Cavo M</searchLink>; Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Chai+Y%22">Chai Y</searchLink>; Karyopharm Therapeutics Inc, Newton, MA, USA.<br /><searchLink fieldCode="AU" term="%22Jeha+J%22">Jeha J</searchLink>; Karyopharm Therapeutics Inc, Newton, MA, USA.<br /><searchLink fieldCode="AU" term="%22Arazy+M%22">Arazy M</searchLink>; Karyopharm Therapeutics Inc, Newton, MA, USA.<br /><searchLink fieldCode="AU" term="%22Shah+J%22">Shah J</searchLink>; Karyopharm Therapeutics Inc, Newton, MA, USA.<br /><searchLink fieldCode="AU" term="%22Shacham+S%22">Shacham S</searchLink>; Karyopharm Therapeutics Inc, Newton, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kauffman+MG%22">Kauffman MG</searchLink>; Karyopharm Therapeutics Inc, Newton, MA, USA.<br /><searchLink fieldCode="AU" term="%22Richardson+PG%22">Richardson PG</searchLink>; Dana Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Grosicki+S%22">Grosicki S</searchLink>; Medical University of Silesia, Katowice, Poland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101468937%22">Journal of hematology & oncology</searchLink> [J Hematol Oncol] 2021 Apr 13; Vol. 14 (1), pp. 59. <i>Date of Electronic Publication: </i>2021 Apr 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Biomed+Central%22">Biomed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101468937 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1756-8722 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217568722%22">17568722 </searchLink><i>NLM ISO Abbreviation: </i>J Hematol Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33849608 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s13045-021-01071-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 59 Titles: – TitleFull: Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mateos MV – PersonEntity: Name: NameFull: Gavriatopoulou M – PersonEntity: Name: NameFull: Facon T – PersonEntity: Name: NameFull: Auner HW – PersonEntity: Name: NameFull: Leleu X – PersonEntity: Name: NameFull: Hájek R – PersonEntity: Name: NameFull: Dimopoulos MA – PersonEntity: Name: NameFull: Delimpasi S – PersonEntity: Name: NameFull: Simonova M – PersonEntity: Name: NameFull: Špička I – PersonEntity: Name: NameFull: Pour L – PersonEntity: Name: NameFull: Kriachok I – PersonEntity: Name: NameFull: Pylypenko H – PersonEntity: Name: NameFull: Doronin V – PersonEntity: Name: NameFull: Usenko G – PersonEntity: Name: NameFull: Benjamin R – PersonEntity: Name: NameFull: Dolai TK – PersonEntity: Name: NameFull: Sinha DK – PersonEntity: Name: NameFull: Venner CP – PersonEntity: Name: NameFull: Garg M – PersonEntity: Name: NameFull: Stevens DA – PersonEntity: Name: NameFull: Quach H – PersonEntity: Name: NameFull: Jagannath S – PersonEntity: Name: NameFull: Moreau P – PersonEntity: Name: NameFull: Levy M – PersonEntity: Name: NameFull: Badros AZ – PersonEntity: Name: NameFull: Anderson LD Jr – PersonEntity: Name: NameFull: Bahlis NJ – PersonEntity: Name: NameFull: Cavo M – PersonEntity: Name: NameFull: Chai Y – PersonEntity: Name: NameFull: Jeha J – PersonEntity: Name: NameFull: Arazy M – PersonEntity: Name: NameFull: Shah J – PersonEntity: Name: NameFull: Shacham S – PersonEntity: Name: NameFull: Kauffman MG – PersonEntity: Name: NameFull: Richardson PG – PersonEntity: Name: NameFull: Grosicki S IsPartOfRelationships: – BibEntity: Dates: – D: 13 M: 04 Text: 2021 Apr 13 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1756-8722 Numbering: – Type: volume Value: 14 – Type: issue Value: 1 Titles: – TitleFull: Journal of hematology & oncology Type: main |
| ResultId | 1 |